Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.
Cancer Immunol Immunother. 2023 Jul;72(7):2443-2458. doi: 10.1007/s00262-023-03430-6. Epub 2023 Apr 5.
Cancer Immunol Immunother. 2023.
PMID: 37016126
Free PMC article.
Clinical Trial.
Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies.
Naing A, Infante J, Goel S, Burris H, Black C, Marshall S, Achour I, Barbee S, May R, Morehouse C, Pollizzi K, Song X, Steele K, Elgeioushi N, Walcott F, Karakunnel J, LoRusso P, Weise A, Eder J, Curti B, Oberst M.
Naing A, et al. Among authors: elgeioushi n.
J Immunother Cancer. 2019 Aug 22;7(1):225. doi: 10.1186/s40425-019-0665-2.
J Immunother Cancer. 2019.
PMID: 31439037
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors.
Balmanoukian AS, Infante JR, Aljumaily R, Naing A, Chintakuntlawar AV, Rizvi NA, Ross HJ, Gordon M, Mallinder PR, Elgeioushi N, González-García I, Standifer N, Cann J, Durham N, Rahimian S, Kumar R, Denlinger CS.
Balmanoukian AS, et al. Among authors: elgeioushi n.
Clin Cancer Res. 2020 Dec 1;26(23):6196-6203. doi: 10.1158/1078-0432.CCR-20-0452. Epub 2020 Sep 4.
Clin Cancer Res. 2020.
PMID: 32887725
Clinical Trial.
Item in Clipboard
Pharmacokinetics and pharmacodynamics of MEDI0680, a fully human anti-PD-1 monoclonal antibody, in patients with advanced malignancies.
Song X, Khan AA, Zhou D, Elgeioushi N, Walcott F, Ren S, Gibbs M.
Song X, et al. Among authors: elgeioushi n.
Cancer Chemother Pharmacol. 2022 Mar;89(3):373-382. doi: 10.1007/s00280-022-04396-5. Epub 2022 Feb 8.
Cancer Chemother Pharmacol. 2022.
PMID: 35133489
Item in Clipboard
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial.
Garon EB, Spira AI, Goldberg SB, Chaft JE, Papadimitrakopoulou V, Cascone T, Antonia SJ, Brahmer JR, Camidge DR, Powderly JD, Wozniak AJ, Felip E, Wu S, Ascierto ML, Elgeioushi N, Awad MM.
Garon EB, et al. Among authors: elgeioushi n.
J Thorac Oncol. 2023 Aug;18(8):1094-1102. doi: 10.1016/j.jtho.2023.04.020. Epub 2023 May 4.
J Thorac Oncol. 2023.
PMID: 37146752
Free article.
Clinical Trial.
Item in Clipboard
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study.
Goldberg A, Geppert T, Schiopu E, Frech T, Hsu V, Simms RW, Peng SL, Yao Y, Elgeioushi N, Chang L, Wang B, Yoo S.
Goldberg A, et al. Among authors: elgeioushi n.
Arthritis Res Ther. 2014 Feb 24;16(1):R57. doi: 10.1186/ar4492.
Arthritis Res Ther. 2014.
PMID: 24559157
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite